Literature DB >> 18576339

Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al.

Thi Huyen Tran Doan, Xavier Chevalier, Jean Marie Leparc, Pascal Richette, Thomas Bardin, Romain Forestier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18576339     DOI： 10.1002/art.23552

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.

Authors:  Axel Finckh; Geraldine M Mc Carthy; Anne Madigan; Daniel Van Linthoudt; Marcel Weber; David Neto; Georges Rappoport; Sandra Blumhardt; Diego Kyburz; Pierre-Andre Guerne
Journal:  Arthritis Res Ther       Date:  2014-10-15       Impact factor: 5.156

Review 2.  Therapy for CPPD: Options and Evidence.

Authors:  Mariano Andrés; Francisca Sivera; Eliseo Pascual
Journal:  Curr Rheumatol Rep       Date:  2018-04-19       Impact factor: 4.592

Review 3.  Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors:  Abhishek Abhishek; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2010-11-23       Impact factor: 20.543

4.  Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?

Authors:  Eliseo Pascual; Mariano Andrés; Francisca Sivera
Journal:  Arthritis Res Ther       Date:  2015-04-01       Impact factor: 5.156

Review 5.  Treatment of nongout joint deposition diseases: an update.

Authors:  Tristan Pascart; Pascal Richette; René-Marc Flipo
Journal:  Arthritis       Date:  2014-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.